AIP
ANRO icon

Ameritas Investment Partners’s Alto Neuroscience ANRO Stock Holding History

Ameritas Investment Partners’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,164
Closed -$4.67K – 3366
2025
Q1 		$4.67K Hold
2,164
– – ﹤0.01% 2987
2024
Q4 		$9.15K Hold
2,164
– – ﹤0.01% 2927
2024
Q3 		$24.8K Buy
2,164
+1,295
+149% +$15.8K ﹤0.01% 2552
2024
Q2 		$9.29K Buy
+869
New +$11.3K ﹤0.01% 2948

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Ameritas Investment Partners's ANRO Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Alto Neuroscience (ANRO) in Q2 2025, closing a stake of 2,164 shares — an estimated $4.67K sold.

Ameritas Investment Partners first reported a position in ANRO in Q2 2024 and held it in 4 quarters. The position peaked at $24.8K in Q3 2024. 80 funds tracked by Wall St. Rank hold ANRO as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Alto Neuroscience position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,164 Alto Neuroscience shares in Q2 2025, an estimated $4.67K.
  • Ameritas Investment Partners first reported a position in Alto Neuroscience in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's Alto Neuroscience position peaked at $24.8K in Q3 2024.
  • 80 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.